- Home
- AGYS vs CNTA Comparison
AGYS vs CNTA Comparison
Compare AGYS & CNTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AGYS
- CNTA
- Stock Information
- Founded
- AGYS 1963
- CNTA 2020
- Country
- AGYS United States
- CNTA United Kingdom
- Employees
- AGYS N/A
- CNTA N/A
- Industry
- AGYS EDP Services
- CNTA Biotechnology: Pharmaceutical Preparations
- Sector
- AGYS Technology
- CNTA Health Care
- Exchange
- AGYS Nasdaq
- CNTA Nasdaq
- Market Cap
- AGYS 2.4B
- CNTA 2.2B
- IPO Year
- AGYS N/A
- CNTA 2021
- Fundamental
- Price
- AGYS $71.45
- CNTA $16.87
- Analyst Decision
- AGYS Strong Buy
- CNTA Strong Buy
- Analyst Count
- AGYS 5
- CNTA 8
- Target Price
- AGYS $133.00
- CNTA $23.17
- AVG Volume (30 Days)
- AGYS 402.3K
- CNTA 1.0M
- Earning Date
- AGYS 05-12-2025
- CNTA 03-27-2025
- Dividend Yield
- AGYS N/A
- CNTA N/A
- EPS Growth
- AGYS N/A
- CNTA N/A
- EPS
- AGYS 0.79
- CNTA N/A
- Revenue
- AGYS $263,572,999.00
- CNTA $6,853,000.00
- Revenue This Year
- AGYS $17.25
- CNTA N/A
- Revenue Next Year
- AGYS $20.76
- CNTA N/A
- P/E Ratio
- AGYS $90.55
- CNTA N/A
- Revenue Growth
- AGYS 15.53
- CNTA N/A
- 52 Week Low
- AGYS $71.37
- CNTA $7.75
- 52 Week High
- AGYS $142.64
- CNTA $19.09
- Technical
- Relative Strength Index (RSI)
- AGYS 27.86
- CNTA 52.95
- Support Level
- AGYS $72.72
- CNTA $15.30
- Resistance Level
- AGYS $82.23
- CNTA $17.29
- Average True Range (ATR)
- AGYS 3.27
- CNTA 1.10
- MACD
- AGYS 0.40
- CNTA 0.11
- Stochastic Oscillator
- AGYS 0.74
- CNTA 67.37
About AGYS Agilysys Inc.
Agilysys Inc has been a leader in hospitality software, delivering innovative cloud-native SaaS and on-premise solutions for hotels, resorts and cruise lines, casinos, corporate food service management, restaurants, universities, stadiums, and healthcare. The Company's software solutions include point-of-sale (POS), property management (PMS), inventory and procurement, payments, and related applications that manage and enhance the entire guest journey. Agilysys also is known for its world-class customer-centric service.
About CNTA Centessa Pharmaceuticals plc
Centessa Pharmaceuticals PLC is a clinical-stage pharmaceutical company. The company's pipeline assets include 1) SerpinPC for Hemophilia A, B, 2) LB101 for Solid Tumors, 3) ORX750 for Narcolepsy Type 1 (NT1) and other sleep disorders, 4) MGX292 Pulmonary Arterial Hypertension (PAH) and 5) Undisclosed for Solid Tumors.